In accordance with the Food and Drug Safety Administration's change order for drug manufacturing (import) product approval (Drug Management Division-No. 9691, effective date 2009.10.7), the precautions for use of the following products have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
- Next -
1.Atenol tablets
2. Preparations containing lactose
- Limerin capsule, Ecrovar tablet, Ecrova tablet 400mg, Alprin tablet, Hedak capsule, Rihel tablet, Dymit tablet 250mg, Dilopine long-acting tablet, Acer tablet, Rosazole tablet, Lepoxin tablet, Azela tablet, Levoprene tablet, Topim tablet, Cadillan tablet, Cardil tablet 1mg, Glymin tablet, Euronal extended-release tablet, Roxonal tablet, Palmcrova tablets, Diropine long-acting tablets 2.5 mg, Avenal tablets, Cilapril tablets, Cadillan tablets 12.5 mg, Inhiplat tablets, Euroscan tablets, Melix capsules, Rosata tablets, Atroban tablets, Pictos tablets, Rosata Plus tablets, Rosata Plus F tablets, Alloscan tablets, Starisan tablets, Pronavi tablets, Mebix tablets, Silumin capsules 11.3 mg, Silumin capsule 16.95mg
3. Soybean oil-containing preparations
- Celtic soft capsule